04/16/2024
3:34 PM | Athira Pharma (Issuer)
San Martin Javier (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/16/2024
3:37 PM | Athira Pharma (Issuer)
San Martin Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
7:32 AM | Athira Pharma (Filer)
| Form DEF 14A | |
04/09/2024
7:34 AM | Athira Pharma (Filer)
| Form DEFA14A | |
04/09/2024
7:35 AM | Athira Pharma (Filer)
| Form ARS | |
03/28/2024
7:47 AM | Athira Pharma (Filer)
| Form PRE 14A | |
02/22/2024
3:34 PM | Athira Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
02/22/2024
3:15 PM | Athira Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/16/2024
3:46 PM | Athira Pharma (Issuer)
Lenington Rachel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:48 PM | Athira Pharma (Issuer)
Gengos Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:54 PM | Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:32 PM | Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
| Form 4/A | |
02/16/2024
3:34 PM | Athira Pharma (Issuer)
Gengos Andrew (Reporting)
| Form 4/A | |
02/16/2024
3:37 PM | Athira Pharma (Issuer)
Worthington Mark (Reporting)
| Form 4/A | |
02/16/2024
3:38 PM | Athira Pharma (Issuer)
Litton Mark James (Reporting)
| Form 4/A | |
02/16/2024
3:40 PM | Athira Pharma (Issuer)
Lenington Rachel (Reporting)
| Form 4/A | |
01/08/2024
3:36 PM | Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:38 PM | Athira Pharma (Issuer)
Worthington Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:40 PM | Athira Pharma (Issuer)
Litton Mark James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:42 PM | Athira Pharma (Issuer)
Gengos Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:45 PM | Athira Pharma (Issuer)
MOEBIUS HANS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:35 PM | Athira Pharma (Issuer)
Lenington Rachel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
6:11 AM | Athira Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
4:24 PM | Athira Pharma (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:15 PM | Athira Pharma (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
07/07/2023
3:35 PM | Athira Pharma (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
06/09/2023
4:06 PM | Athira Pharma (Issuer)
Gengos Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
6:35 PM | Athira Pharma (Issuer)
MOEBIUS HANS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
6:36 PM | Athira Pharma (Issuer)
Gengos Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
4:56 PM | Athira Pharma (Issuer)
PICKERING GRANT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
4:58 PM | Athira Pharma (Issuer)
FLUKE JOHN M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
5:01 PM | Athira Pharma (Issuer)
Panzara Michael A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
5:04 PM | Athira Pharma (Issuer)
EDELMAN JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
5:06 PM | Athira Pharma (Issuer)
Kosacz Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
5:08 PM | Athira Pharma (Issuer)
JOHNSON JAMES A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
5:11 PM | Athira Pharma (Issuer)
Romano Kelly A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
4:51 PM | Athira Pharma (Issuer)
Gengos Andrew (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/22/2023
4:53 PM | Athira Pharma (Issuer)
Gengos Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2023
7:00 AM | Athira Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
